Orchard therapeutics plc - adr
WebMar 6, 2024 · Orchard Therapeutics Plc ADR (ORTX) reported a Quarter December 2024 loss of $0.06 per share on revenue of $7.0 million. The consensus estimate was a loss of $0.18 per share on revenue of $5.0 million. Revenue grew … WebFeb 23, 2024 · As of February 23, 2024, Orchard Therapeutics PLC - ADR had a $69.5 million market capitalization, putting it in the 28th percentile of companies in the Pharmaceuticals industry. Orchard Therapeutics PLC - ADR does not have a meaningful P/E due to negative earnings over the last 12 trailing months.
Orchard therapeutics plc - adr
Did you know?
WebWe’re building on decades of research to apply our HSC gene therapy platform to areas of significant medical need where we believe it may have distinct therapeutic advantages. … OTL-200 (MLD) About MLD. Metachromatic leukodystrophy (MLD) is a rare and life … For more information and to apply, please contact [email protected]. … Orchard was founded in 2015—but our roots run deeper, going back to some of the … What’s in an Orchard? Orchards are more than the sum of the fruit they produce. … The Importance of Orchard’s Core Values for Our Bold Vision. As we pass the one … Patient advocacy inquiries: [email protected] To … Orchard is building on decades of research and advancements in the field of gene … Metachromatic leukodystrophy (MLD) is a rare and life-threatening inherited … Orchard and our research partners are conducting clinical trials of … Web美股吧--东方财富网旗下股票主题社区，实时行情评论和个股交流让你感受到证券经济的力量。
WebOrchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders.
WebApr 11, 2024 · Get the latest Orchard Therapeutics PLC Sponsored ADR ORTX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. WebOrchard Therapeutics plc - ADR (ORTX) shares closed 5.0% lower than its previous 52 week low, giving the company a market cap of $279M. The stock is currently down 48.4% year …
http://www.adr.org/OfficeLocations
WebIndependent Director, Orchard Therapeutics Plc Steven M. Altschuler is an American businessperson who founded Spark Therapeutics, Inc. and who has been the head of 9 different companies. shroud sand screenWebHealth Care/Life Sciences -0.19% Overview Company Info Orchard Therapeutics PLC ADR 245 Hammersmith Road London Greater London W6 8PW United Kingdom Email Website … theory a and theory b psychology toolsWebThe Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. theory a and theory b panic disorderWeb-597.82% Revenue (TTM) Below Average $22.59 million Year-Over-Year Fundamentals See More Orchard Therapeutics plc - ADR Vitals Updated 03/29/2024 Quotes delayed at least … shrouds apex legend settingsWebAnalyst Ratings for Orchard Therapeutics Plc ADR (ORTX) provide recommendations made by outside industry experts. theory a and theory b ocdWebOrchard Therapeutics plc - ADR’s revenue jumped +Inf% since last year same period to $4.37Mn in the Q2 2024. On a quarterly growth basis, Orchard Therapeutics plc - ADR has generated -20.93% fall in its revenue since last 3-months. theory abc applicationWebOct 21, 2024 · Company summary. Orchard Therapeutics is a biotechnology company, develops and commercializes transformative ex-vivo autologous hematopoietic stem cell … theory a and theory b social anxiety